In SLE and RA patients, Th17 cells exhibit high ROCK activity that is inhibited by Y276327, KD025, or simvastatin; IL-17 and IL-21 production is also decreased by purified SLE T cells or Th17 cells (Rozo et al., 2017). Here, IL17A is linked to systemic lupus erythematosus.